Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Milione

Showing results (81-90 of 206) with videos related to

Pageof 21
Sort By:
Neuroendocrinology|February 25, 2016
Four Neuroendocrine Tumor Types and Neuroendocrine Carcinoma of the Duodenum: Analysis of 203 CasesAlessandro Vanoli, Stefano La Rosa, Catherine Klersy, et al.
Chinese Journal of Cancer|June 9, 2016
Whole exome sequencing and single nucleotide polymorphism array analyses to identify germline alterations in genes associated with testosterone metabolism in a patient with androgen insensitivity syndrome and early-onset colorectal cancerVittoria Disciglio, Andrea Devecchi, Orazio Palumbo, et al.
Scientific Reports|October 5, 2019
Toll-like receptor 3 as a new marker to detect high risk early stage Non-Small-Cell Lung Cancer patientsFrancesca Bianchi, Massimo Milione, Patrizia Casalini, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 30, 2019
Lynch syndrome-related non-endometrioid endometrial cancer: analysis of outcomesGiorgio Bogani, Maria Grazia Tibiletti, Maria Teresa Ricci, et al.
Future Oncology (London, England)|June 6, 2017
Rationale and protocol of MetNET-2 trial: Lanreotide Autogel plus metformin in advanced gastrointestinal or lung neuroendocrine tumorsSara Pusceddu, Natalie Prinzi, Giuseppe Lo Russo, et al.
World Journal of Gastroenterology|August 11, 2020
Histopathological landscape of rare oesophageal neoplasmsGianluca Businello, Carlo Alberto Dal Pozzo, Marta Sbaraglia, et al.
Plos One|April 3, 2014
Gain of ALK gene copy number may predict lack of benefit from anti-EGFR treatment in patients with advanced colorectal cancer and RAS-RAF-PI3KCA wild-type statusFilippo Pietrantonio, Claudia Maggi, Maria Di Bartolomeo, et al.
Oncoimmunology|June 15, 2018
pH regulators to target the tumor immune microenvironment in human hepatocellular carcinomaOlga Kuchuk, Alessandra Tuccitto, Davide Citterio, et al.
International Journal of Cancer|December 7, 2018
Impact of systemic and tumor lipid metabolism on everolimus efficacy in advanced pancreatic neuroendocrine tumors (pNETs)Claudio Vernieri, Sara Pusceddu, Giovanni Fucà, et al.
Oncotarget|September 15, 2017
Identification and characterization of a novel <i>SCYL3-NTRK1</i> rearrangement in a colorectal cancer patientMassimo Milione, Elena Ardini, Jason Christiansen, et al.
Pageof 21

Showing results (81-90 of 206) with videos related to

Sort By:
Pageof 21
Neuroendocrinology|February 25, 2016
Four Neuroendocrine Tumor Types and Neuroendocrine Carcinoma of the Duodenum: Analysis of 203 CasesAlessandro Vanoli, Stefano La Rosa, Catherine Klersy, et al.
Chinese Journal of Cancer|June 9, 2016
Whole exome sequencing and single nucleotide polymorphism array analyses to identify germline alterations in genes associated with testosterone metabolism in a patient with androgen insensitivity syndrome and early-onset colorectal cancerVittoria Disciglio, Andrea Devecchi, Orazio Palumbo, et al.
Scientific Reports|October 5, 2019
Toll-like receptor 3 as a new marker to detect high risk early stage Non-Small-Cell Lung Cancer patientsFrancesca Bianchi, Massimo Milione, Patrizia Casalini, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 30, 2019
Lynch syndrome-related non-endometrioid endometrial cancer: analysis of outcomesGiorgio Bogani, Maria Grazia Tibiletti, Maria Teresa Ricci, et al.
Future Oncology (London, England)|June 6, 2017
Rationale and protocol of MetNET-2 trial: Lanreotide Autogel plus metformin in advanced gastrointestinal or lung neuroendocrine tumorsSara Pusceddu, Natalie Prinzi, Giuseppe Lo Russo, et al.
World Journal of Gastroenterology|August 11, 2020
Histopathological landscape of rare oesophageal neoplasmsGianluca Businello, Carlo Alberto Dal Pozzo, Marta Sbaraglia, et al.
Plos One|April 3, 2014
Gain of ALK gene copy number may predict lack of benefit from anti-EGFR treatment in patients with advanced colorectal cancer and RAS-RAF-PI3KCA wild-type statusFilippo Pietrantonio, Claudia Maggi, Maria Di Bartolomeo, et al.
Oncoimmunology|June 15, 2018
pH regulators to target the tumor immune microenvironment in human hepatocellular carcinomaOlga Kuchuk, Alessandra Tuccitto, Davide Citterio, et al.
International Journal of Cancer|December 7, 2018
Impact of systemic and tumor lipid metabolism on everolimus efficacy in advanced pancreatic neuroendocrine tumors (pNETs)Claudio Vernieri, Sara Pusceddu, Giovanni Fucà, et al.
Oncotarget|September 15, 2017
Identification and characterization of a novel <i>SCYL3-NTRK1</i> rearrangement in a colorectal cancer patientMassimo Milione, Elena Ardini, Jason Christiansen, et al.
Pageof 21